Pod těmito názvy můžete látku najít v jiných zdrojích
ALLOGENEIC UMBILICAL CORD CD34+ ENRICHED BLOOD CELLS. THE DRUG SUBSTANCE CONSISTS OF THE TOTAL PROGENY GENERATED FROM CULTURE OF ENRICHED CD34+ UMBILICAL CORD BLOOD CELLS THAT HAVE BEEN CULTURED EX VIVO IN THE PRESENCE OF IMMOBILISED ENGINEERED NOTCH LIGAND DELTA1^(EXT -IGG) (DXI) AND RECOMBINANT CYTOKINES. CELL PHENOTYPE DISTRIBUTION: CD3, CD7, CD14, CD15, CD16+CD56+ (BOTH STAINED TOGETHER), CD34, CD41, CD45RA, CD56, AND CD90. CELLS ARE INTENDED TO ENHANCE RECONSTITUTION IN HEMATOPOIETIC STEM CELL TRANSPLANTATION PATIENTS WITH HIGH RISK OF IATROGENIC CONDITIONING-RELATED PROLONGED PANCYTOPENIA